← All trials
NCT04462029
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 5, 2020
- Primary completion
- Oct 7, 2020
- Completion date
- Oct 7, 2020
- First posted
- Jul 8, 2020
- Last posted
- Oct 28, 2020
- Enrollment
- 18
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Boryung Pharmaceutical CompanyLead sponsor
- Inha UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.